期刊
DIABETES
卷 63, 期 2, 页码 410-420出版社
AMER DIABETES ASSOC
DOI: 10.2337/db13-0991
关键词
-
资金
- Bontius Foundation
- Medical Research Council [MC_UU_12012/3, G0600717, G0600717B, MC_UU_12012/5/B] Funding Source: researchfish
- MRC [G0600717, MC_UU_12012/3] Funding Source: UKRI
Upon a nutrient challenge, L cells produce glucagon-like peptide 1 (GLP-1), a powerful stimulant of insulin release. Strategies to augment endogenous GLP-1 production include promoting L-cell differentiation and increasing L-cell number. Here we present a novel in vitro platform to generate functional L cells from three-dimensional cultures of mouse and human intestinal crypts. We show that short-chain fatty acids selectively increase the number of L cells, resulting in an elevation of GLP-1 release. This is accompanied by the upregulation of transcription factors associated with the endocrine lineage of intestinal stem cell development. Thus, our platform allows us to study and modulate the development of L cells in mouse and human crypts as a potential basis for novel therapeutic strategies in patients with type 2 diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据